Home / Private raises / INFLAMMATIX, INC.

INFLAMMATIX, INC.

Biotechnology · Sunnyvale, California · $47.4M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-19D (new)$47.4M$57.3M14506(b)Equity, Options/warrants, Security to be acquired, Offer and sale of Series E and E-1 Preferred Stock and Common Stock issuable upon conversion thereof. Certain exchanged Common Stock were issued for shares of a specific series of Preferred Stock. Warrants to purchase Series E-2 Preferred Stock.Apr 5SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Issuer

IndustryBiotechnology
LocatedSunnyvale, California
EntityCorporation
IncorporatedDelaware
SEC CIK1801477

People named in the latest filing

NameRole
TIMOTHY E. SWEENEYExecutive Officer, Director
HEINER DREISMANNDirector
FLORIAN KAINZINGERDirector
INGO CHAKRAVARTYDirector
STEVEN TABLAKDirector
JONATHAN ROMANOWSKYDirector
DAVID PERSINGDirector

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?